Abbott Laboratories (ABT) results explained: sales up 12%

Quantooo Lab · 2026-10-21

What happened?

Abbott Laboratories (ABT) reported results on 21 Oct, covering the 9 months to 30 Sep.

The numbers in plain words

Sales were up 11.9% compared with the same period a year earlier. Out of every 100 of sales, about 12 was left after running costs (operating margin 12.0%), lower than a year earlier (17.6%). The company is funded more by borrowing than a year ago (53% of assets vs 39%).

Source: the company's 10-Q filed 2026-11-04.

How did the share price react?

Since the results, the share price has moved +12.75% (to the close of 4 Nov), while the S&P 500 moved −0.29%.

What changed in our score?

Our score went from 36 to 50 out of 100; the fundamentals part went from 24 to 26. Every step of the calculation: ABT stock page.

How bumpy could the next month be?

Our volatility model expects the next month to be bumpier than usual for ABT (23% a year vs a normal 21%).

What does it mean?

Results describe the past few months. They don't tell you where the price goes next, and our own tests found our scores don't reliably predict that either.

Educational, not investment advice.